Cannabis-based drug for childhood epilepsy approved for use in UK By Green Cross on September 23, 2019 in MMJ Info The first cannabis-based medicine for childhood epilepsy is expected to be available soon in the UK and the rest of Europe after its UK manufacturer, GW Pharmaceuticals, received the green light from European authorities. Read more »
Comments are closed.